Serum lipids concentration on prognosis of high-grade glioma

被引:2
作者
Huang, Fei [1 ,3 ,4 ,5 ]
Li, Shan [2 ,4 ,5 ]
Wang, Xuezhen [2 ]
Wang, Caihong [2 ]
Pan, Xiaoxian [2 ]
Chen, Xiuying [2 ,4 ,5 ]
Zhang, Weijian [2 ,4 ,5 ]
Hong, Jinsheng [2 ,4 ,5 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Cent Lab, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China
[2] Fujian Med Univ, Canc Ctr, Dept Radiotherapy, Affiliated Hosp 1, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China
[3] Fujian Med Univ, Affiliated Hosp 1, Cent Lab, Natl Reg Med Ctr, Binhai Campus, Fuzhou 350212, Fujian, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Fujian Higher Educ Inst, Key Lab Radiat Biol, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China
[5] Fujian Med Univ, Fujian Prov Key Lab Precis Med Canc, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China
关键词
Cholesterol; LDL; HDL; Glioma; High-grade; Prognosis; TUMOR-TREATING FIELDS; CHOLESTEROL; GLIOBLASTOMA; IDH; SURVIVAL; THERAPY; DIET; TERT; LDL; HDL;
D O I
10.1007/s10552-023-01710-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective To investigate the effect of serum lipids concentration on the prognosis of high-grade glioma patients undergoing postoperative radiotherapy. Methods Retrospective analysis of the patients with high-grade glioma who received postoperative Intensity Modulated Radiotherapy between 13 May 2013 and 12 September 2018 was performed. The patients were grouped according to the average values of serum total cholesterol, LDL, and HDL concentration in peripheral blood (before surgery, 6 months after therapy). Cox proportional hazards model was performed to determine whether the total cholesterol concentration, LDL concentration, and HDL concentration in peripheral blood before therapy and their changes after therapy were factors influencing the prognosis. Results The results of COX regression analysis showed that the independent prognostic factors of high-grade glioma patients were pathological grade, the extent of resection, serum cholesterol concentration pre-surgery, and the change of LDL concentration from pre-surgery to post-therapy. The prognosis of patients with high serum total cholesterol concentration before therapy was worse than those of patients with low total cholesterol concentration. The 5-year survival rate and the median survival time of patients with high serum total cholesterol concentration before therapy were 4.9% and 23.6 months, but the low cholesterol concentration group were 19.6% and 24.5 months, respectively. Besides, the average serum LDL concentration in high-grade glioma patients gradually increased after therapy. The 5-year survival rate of patients and the median survival time with elevated LDL concentration after therapy is 11.8% and 20.4 months, but the reduced LDL concentration group was 16.7% and 28.4 months, respectively. The total cholesterol and LDL concentration increased significantly after therapy in Grade IV patients while Grade III patients did not. Conclusions The cholesterol concentration before therapy and LDL concentration change from pre-surgery to post-therapy are the factors that affect the prognosis of high-grade glioma patients who have undergone postoperative radiotherapy. In the final analysis, the high serum cholesterol pre-surgery and the increased in serum LDL concentration from pre-surgery to post-therapy were associated with worse survival of patients.
引用
收藏
页码:801 / 811
页数:11
相关论文
共 40 条
  • [31] ESTRO-ACROP guideline "target delineation of glioblastomas"
    Niyazi, Maximilian
    Brada, Michael
    Chalmers, Anthony J.
    Combs, Stephanie E.
    Erridge, Sara C.
    Fiorentino, Alba
    Grosu, Anca L.
    Lagerwaard, Frank J.
    Minniti, Giuseppe
    Mirimanoff, Rene-Olivier
    Ricardi, Umberto
    Short, Susan C.
    Weber, Damien C.
    Belka, Claus
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 118 (01) : 35 - 42
  • [32] Increased levels of cholesterol esters in glioma tissue and surrounding areas of human brain
    Nygren, C
    vonHolst, H
    Mansson, JE
    Fredman, P
    [J]. BRITISH JOURNAL OF NEUROSURGERY, 1997, 11 (03) : 216 - 220
  • [33] IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas
    Olar, Adriana
    Wani, Khalida M.
    Alfaro-Munoz, Kristin D.
    Heathcock, Lindsey E.
    van Thuijl, Hinke F.
    Gilbert, Mark R.
    Armstrong, Terri S.
    Sulman, Erik P.
    Cahill, Daniel P.
    Vera-Bolanos, Elizabeth
    Yuan, Ying
    Reijneveld, Jaap C.
    Ylstra, Bauke
    Wesseling, Pieter
    Aldape, Kenneth D.
    [J]. ACTA NEUROPATHOLOGICA, 2015, 129 (04) : 585 - 596
  • [34] Glioblastoma and Other Malignant Gliomas A Clinical Review
    Omuro, Antonio
    DeAngelis, Lisa M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (17): : 1842 - 1850
  • [35] Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
    Schalper, Kurt A.
    Rodriguez-Ruiz, Maria E.
    Diez-Valle, Ricardo
    Lopez-Janeiro, Alvaro
    Porciuncula, Angelo
    Idoate, Miguel A.
    Inoges, Susana
    De Andrea, Carlos
    Lopez-Diaz de Cerio, Ascension
    Tejada, Sonia
    Berraondo, Pedro
    Villarroel-Espindola, Franz
    Choi, Jungmin
    Gurpide, Alfonso
    Giraldez, Miriam
    Goicoechea, Iosune
    Gallego Perez-Larraya, Jaime
    Sanmamed, Miguel F.
    Perez-Gracia, Jose L.
    Melero, Ignacio
    [J]. NATURE MEDICINE, 2019, 25 (03) : 470 - +
  • [36] Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients
    Tang, Qiu
    Hu, Qiao-Ying
    Piao, Yong-Feng
    Hua, Yong-Hong
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 2585 - 2591
  • [37] Epidemiologic and Molecular Prognostic Review of Glioblastoma
    Thakkar, Jigisha P.
    Dolecek, Therese A.
    Horbinski, Craig
    Ostrom, Quinn T.
    Lightner, Donita D.
    Barnholtz-Sloan, Jill S.
    Villano, John L.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (10) : 1985 - 1996
  • [38] An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers
    Villa, Genaro R.
    Hulce, Jonathan J.
    Zanca, Ciro
    Bi, Junfeng
    Ikegami, Shiro
    Cahill, Gabrielle L.
    Gu, Yuchao
    Lum, Kenneth M.
    Masui, Kenta
    Yang, Huijun
    Rong, Xin
    Hong, Cynthia
    Turner, Kristen M.
    Liu, Feng
    Hon, Gary C.
    Jenkins, David
    Martini, Michael
    Armando, Aaron M.
    Quehenberger, Oswald
    Cloughesy, Timothy F.
    Furnari, Frank B.
    Cavenee, Webster K.
    Tontonoz, Peter
    Gahman, Timothy C.
    Shiau, Andrew K.
    Cravatt, Benjamin F.
    Mischel, Paul S.
    [J]. CANCER CELL, 2016, 30 (05) : 683 - 693
  • [39] Pregnenolone, a cholesterol metabolite, induces glioma cell apoptosis via activating extrinsic and intrinsic apoptotic pathways
    Xiao, Xiao
    Chen, Lijun
    Ouyang, Ying
    Zhu, Wenbo
    Qiu, Pengxin
    Su, Xinwen
    Dou, Yunling
    Tang, Lipeng
    Yan, Min
    Zhang, Haipeng
    Yang, Xiaoxiao
    Xu, Dong
    Yan, Guangmei
    [J]. ONCOLOGY LETTERS, 2014, 8 (02) : 645 - 650
  • [40] Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
    Zhao, Junfei
    Chen, Andrew X.
    Gartrell, Robyn D.
    Silverman, Andrew M.
    Aparicio, Luis
    Chu, Tim
    Bordbar, Darius
    Shan, David
    Samanamud, Jorge
    Mahajan, Aayushi
    Filip, Ioan
    Orenbuch, Rose
    Goetz, Morgan
    Yamaguchi, Jonathan T.
    Cloney, Michael
    Horbinski, Craig
    Lukas, Rimas V.
    Raizer, Jeffrey
    Rae, Ali I.
    Yuan, Jinzhou
    Canoll, Peter
    Bruce, Jeffrey N.
    Saenger, Yvonne M.
    Sims, Peter
    Iwamoto, Fabio M.
    Sonabend, Adam M.
    Rabadan, Raul
    [J]. NATURE MEDICINE, 2019, 25 (03) : 462 - +